HOME › DRUGS › OSIMERTINIB
ACTIVE SUBSTANCE / INN

OSIMERTINIB

Brand name(s): Tagrisso
EMA LISTED
AUTHORISED
Carcinoma, Non-Small-Cell Lung
ACTIVE SUBSTANCE
Osimertinib
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TagrissoAstraZeneca ABAuthorised01/02/2016Carcinoma, Non-Small-Cell Lung

FULL INTELLIGENCE ON OSIMERTINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →